Pseudoirreversible inhibition elicits persistent efficacy of a sphingosine 1-phosphate receptor 1 antagonist.

MLA

Maruyama, Yuya, et al. “Pseudoirreversible Inhibition Elicits Persistent Efficacy of a Sphingosine 1-Phosphate Receptor 1 Antagonist.” Nature Communications, vol. 15, no. 1, July 2024, p. 5743. EBSCOhost, https://doi.org/10.1038/s41467-024-49893-8.

APA

Maruyama, Y., Ohsawa, Y., Suzuki, T., Yamauchi, Y., Ohno, K., Inoue, H., Yamamoto, A., Hayashi, M., Okuhara, Y., Muramatsu, W., Namiki, K., Hagiwara, N., Miyauchi, M., Miyao, T., Ishikawa, T., Horie, K., Hayama, M., Akiyama, N., Hirokawa, T., & Akiyama, T. (2024). Pseudoirreversible inhibition elicits persistent efficacy of a sphingosine 1-phosphate receptor 1 antagonist. Nature Communications, 15(1), 5743. https://doi.org/10.1038/s41467-024-49893-8

Chicago

Maruyama, Yuya, Yusuke Ohsawa, Takayuki Suzuki, Yuko Yamauchi, Kohsuke Ohno, Hitoshi Inoue, Akitoshi Yamamoto, et al. 2024. “Pseudoirreversible Inhibition Elicits Persistent Efficacy of a Sphingosine 1-Phosphate Receptor 1 Antagonist.” Nature Communications 15 (1): 5743. doi:10.1038/s41467-024-49893-8.